Thank you both, this will be posted shortly on the 16 December 2021 motions wiki page<https://community.icann.org/x/hQWlCg>. Kindest regards, Terri From: council <council-bounces@gnso.icann.org> on behalf of John McElwaine via council <council@gnso.icann.org> Reply-To: John McElwaine <john.mcelwaine@nelsonmullins.com> Date: Monday, December 6, 2021 at 6:17 PM To: "council@gnso.icann.org" <council@gnso.icann.org> Subject: [council] Fwd: EPDP_SPCR_IGO Motion for a Project Change Request Dear Councilors, The below motion is from me. Thanks, John Begin forwarded message: From: Berry Cobb via council <council@gnso.icann.org> Date: December 6, 2021 at 18:32:09 EST To: Terri Agnew via council <council@gnso.icann.org> Subject: [council] EPDP_SPCR_IGO Motion for a Project Change Request Reply-To: Berry Cobb <Berry.Cobb@icann.org> ◄External Email► - From: council-bounces@gnso.icann.org Dear GNSO Councilors, Due to technical difficulties and on behalf of the EPDP on Specific Curative Rights Protections for IGO leadership team, I am submitting one motion to be considered for the 16 December 2021 meeting: 1. Approval of a Project Change Request (PCR) to request additional time to deliver the EPDP Team’s Final Report. Motion and related documents are attached. Thank you. EPDP Leadership Team. _______________________________________________ council mailing list council@gnso.icann.org https://mm.icann.org/mailman/listinfo/council _______________________________________________ By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and the website Terms of Service (https://www.icann.org/privacy/tos). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on. Confidentiality Notice This message is intended exclusively for the individual or entity to which it is addressed. This communication may contain information that is proprietary, privileged, confidential or otherwise legally exempt from disclosure. If you are not the named addressee, you are not authorized to read, print, retain, copy or disseminate this message or any part of it. If you have received this message in error, please notify the sender immediately either by phone (800-237-2000) or reply to this e-mail and delete all copies of this message.